Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Vincent

Showing results (461-470 of 733) with videos related to

Pageof 74
Sort By:
International Journal of Antimicrobial Agents|September 3, 2013
Can changes in renal function predict variations in β-lactam concentrations in septic patients?Giuseppe Stefano Casu, Maya Hites, Frederique Jacobs, et al.
Critical Care Medicine|December 6, 2014
The impact of hospital and ICU organizational factors on outcome in critically ill patients: results from the Extended Prevalence of Infection in Intensive Care studyYasser Sakr, Cora L Moreira, Andrew Rhodes, et al.
The New England Journal of Medicine|March 5, 2010
Comparison of dopamine and norepinephrine in the treatment of shockDaniel De Backer, Patrick Biston, Jacques Devriendt, et al.
Clinical Hemorheology and Microcirculation|January 28, 2017
No relationship between red blood cell distribution width and microcirculatory alterations in septic patientsVito Fontana, Savino Spadaro, Ottavia Bond, et al.
Critical Care (London, England)|January 6, 2016
A few of our favorite unconfirmed ideasJohn J Marini, Luciano Gattinoni, Can Ince, et al.
Critical Care (London, England)|August 16, 2017
Selepressin, a novel selective vasopressin V<sub>1A</sub> agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patientsJames A Russell, Jean-Louis Vincent, Anne Louise Kjølbye, et al.
Journal of Clinical Monitoring and Computing|January 18, 2025
Decision support guided fluid challenges and stroke volume response during high-risk surgery: a post hoc analysis of a randomized controlled trialSean Coeckelenbergh, Joseph Rinehart, Olivier Desebbe, et al.
Critical Care Medicine|May 29, 2003
Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000John C Marshall, Jean-Louis Vincent, Mitchell P Fink, et al.
Intensive Care Medicine|July 26, 2018
Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalkFaeq Husain-Syed, Zaccaria Ricci, Daniel Brodie, et al.
Critical Care Medicine|December 16, 2004
Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsisWilliam L Macias, Benoit Vallet, Gordon R Bernard, et al.
Pageof 74

Showing results (461-470 of 733) with videos related to

Sort By:
Pageof 74
International Journal of Antimicrobial Agents|September 3, 2013
Can changes in renal function predict variations in β-lactam concentrations in septic patients?Giuseppe Stefano Casu, Maya Hites, Frederique Jacobs, et al.
Critical Care Medicine|December 6, 2014
The impact of hospital and ICU organizational factors on outcome in critically ill patients: results from the Extended Prevalence of Infection in Intensive Care studyYasser Sakr, Cora L Moreira, Andrew Rhodes, et al.
The New England Journal of Medicine|March 5, 2010
Comparison of dopamine and norepinephrine in the treatment of shockDaniel De Backer, Patrick Biston, Jacques Devriendt, et al.
Clinical Hemorheology and Microcirculation|January 28, 2017
No relationship between red blood cell distribution width and microcirculatory alterations in septic patientsVito Fontana, Savino Spadaro, Ottavia Bond, et al.
Critical Care (London, England)|January 6, 2016
A few of our favorite unconfirmed ideasJohn J Marini, Luciano Gattinoni, Can Ince, et al.
Critical Care (London, England)|August 16, 2017
Selepressin, a novel selective vasopressin V<sub>1A</sub> agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patientsJames A Russell, Jean-Louis Vincent, Anne Louise Kjølbye, et al.
Journal of Clinical Monitoring and Computing|January 18, 2025
Decision support guided fluid challenges and stroke volume response during high-risk surgery: a post hoc analysis of a randomized controlled trialSean Coeckelenbergh, Joseph Rinehart, Olivier Desebbe, et al.
Critical Care Medicine|May 29, 2003
Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000John C Marshall, Jean-Louis Vincent, Mitchell P Fink, et al.
Intensive Care Medicine|July 26, 2018
Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalkFaeq Husain-Syed, Zaccaria Ricci, Daniel Brodie, et al.
Critical Care Medicine|December 16, 2004
Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsisWilliam L Macias, Benoit Vallet, Gordon R Bernard, et al.
Pageof 74